Covaxin Problems - Search Videos

‘Delay in WHO Nod for Covaxin Suggests Problems Exist’

‘Delay in WHO Nod for Covaxin Suggests Problems Exist’

What is Covaxin, the COVID vaccine not approved in the US?

What is Covaxin, the COVID vaccine not approved in the US?

newsnationnow.com

Covaxin Vaccine FAQ: All That You Need To Know About This Vaccine

Covaxin Vaccine FAQ: All That You Need To Know About This Vaccine

onlymyhealth.com

Covaxin, the homegrown coronavirus vaccine that was authorised for use in January before full clinical trial data, has been declared "safe, immunogenic with no serious side effects" by Lancet that has published its Phase 2 results. Medical journal Lancet has said that efficacy cannot be determined by Phase 2 trials but the vaccine made by Hyderabad-based Bharat Biotech is "safe/immunogenic". The Lancet report says the results reported in the study of Phase 2 results do not permit efficacy assess

Covaxin, the homegrown coronavirus vaccine that was auth…

27.9K viewsMar 9, 2021

Centre to increase production of Covaxin to address shortage of COVID-19 vaccine

Centre to increase production of Covaxin to address shortage of C…

77K views · 947 reactions | #Gravitas | #Covaxin has been denied emergency use authorisation in the US. The vaccine is yet to be listed on the WHO's list of approved vaccines. The lack of global approvals has put a question mark on travel, work & study plans of millions of Indians. Palki S Upadhyay tells you why | WION | Facebook

77K views · 947 reactions | #Gravitas | #Covaxin has been de…

77.8K views5 days ago

Dr Randeep Guleria, Director, AIIMS says Covaxin efficacy data is encouraging but trails will continue. This is an interim Phase 3 result based on 43 infections, but for final results, 130 infections need to be studied. But Dr Guleria says this will go a long way in promoting the vaccine program in the country. | NDTV

Dr Randeep Guleria, Director, AIIMS says Covaxin efficacy data is enco…

17.7K viewsMar 3, 2021

36K views · 425 reactions | India's first indigenous vaccine against C…

36.5K views4 weeks ago

6K views · 68 reactions | A pre-print study of vaccinated healthcare wo…

6.1K views2 weeks ago

23K views · 432 reactions | #DNA: Why is WHO delaying approval fo…

23.1K views2 weeks ago

FacebookZee News English

Covaxin Supply Deficit: What was expected & what is the current sit…

timesnownews.com

Bharat Biotech’s Covaxin safe for children, well-tolerated in 2-18 yea…

The Indian Council of Medical Research has revealed that a mix …

21.6K viewsAug 9, 2021

The US' National Institute of Health has said that India's Covaxin, dev…

6.8K viewsJun 30, 2021

ICMR study reveals that better antibodies are found in people wh…

2.5K viewsAug 9, 2021

WHO delays Covaxin approval, seeks additional clarifications fro…

Covaxin trials for 2-18 age group to begin in 10-12 days: Niti Aayog’s …

Covaxin 100% effective against severe COVID cases: ICMR

Covaxin good & bad news: US agency acclaim; Brazil deal suspe…

Hindustan TimesAniruddh Misra

Bharat Biotechs Covaxin effective against new COVID-19 variants, re…

Covaxin works against Indian-origin variant, finds ICMR-Bharat Biotec…

Covaxin's Phase 2/3 trial on children to be completed by September

Results of Covaxin trials on children likely to be out by September, say…

India TodayIndia Today Web Desk

'Poor design, misleading': ICMR calls out BHU study on Covaxin's …

India TodayIndia Today Health Desk

US drug regulator rejects emergency use approval for Bhara…

India TodayIndia Today Television

Covaxin controversy: Bypassing phases jeopardises system, say e…

India TodayPankaj Upadhyay

covaxin side effects|Ho rhi hai saans sambandhi problems|#ytsh…

202 viewsMay 17, 2024

YouTubeNeetu goswami

Covaxin got approval for phase-III trials: DG ICMR

3K viewsOct 27, 2020

Covaxin jabs still not enough for traveling abroad | WHO delays cle…

India TodayIndia Today Television

vi-BB1mtqIX

See more videos